<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0871-9721</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Imunoalergologia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Imunoalergologia]]></abbrev-journal-title>
<issn>0871-9721</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Alergologia e Imunologia Clínica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0871-97212023000100023</article-id>
<article-id pub-id-type="doi">10.32932/rpia.2023.03.100</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Associação entre urticária crónica espontânea e o consumo de psicofármacos]]></article-title>
<article-title xml:lang="en"><![CDATA[Association between chronic spontaneous urticaria and consumption of psychodrugs]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gouveia]]></surname>
<given-names><![CDATA[Joana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[Inês M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[Eva]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Hospitalar Universitário do Porto Serviço de Imunoalergologia ]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2023</year>
</pub-date>
<volume>31</volume>
<numero>1</numero>
<fpage>23</fpage>
<lpage>29</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S0871-97212023000100023&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S0871-97212023000100023&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S0871-97212023000100023&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Fundamentos:  A urticária carateriza-se pela presença de lesões maculopapulares eritematosas pruriginosas, associadas ou não a angioedema, e estima-se que a urticária crónica afete até 1% da população em algum momento da vida. A urticária crónica espontânea (UCE), pelas suas características clínicas, pode afetar de forma importante o desempenho das atividades diárias e a qualidade do sono. Alguns estudos sugerem que perturbações emocionais poderão ser um fator desencadeante importante na UCE.  Objetivos:  Este estudo teve como objetivo explorar a associação da urticária crónica espontânea com a patologia psiquiátrica avaliando o consumo de psicofármacos por parte dos doentes com UCE.  Métodos:  Estudo retrospetivo de doentes adultos avaliados em primeira consulta de Imunoalergologia ao longo de um ano, onde comparamos os dados de um grupo de estudo com UCE com os de um grupo de controlo que incluiu doentes avaliados ao longo do mesmo período por doença respiratória, emparelhados com o grupo de estudo em género e grupo etário. O uso de psicofármacos pelo doente foi obtido a partir da história clínica e da aplicação da prescrição eletrónica médica (PEM). A análise estatística foi realizada no SPSS versão 22 e, para comparação dos grupos, foi utilizado o teste X2, com intervalo de confiança de 95%. Resultados: Foram incluídos 60 doentes no grupo de estudo com UCE e 120 doentes no grupo de controlo. De forma global não se verificou diferença estatisticamente significativa (p=0.054) no consumo de psicofármacos entre os grupos avaliados. Embora se verifique uma tendência de maior consumo de ansiolíticos e sedativos no grupo de estudo. Quando avaliamos por classe farmacológica, os doentes do grupo de estudo apresentam maior tendência ao consumo de mais do que um psicofármaco (p= 0,017), independentemente do fármaco envolvido.  Conclusões:  Os doentes com UCE apresentam maior tendência ao consumo de mais do que um psicofármaco, independentemente do grupo farmacológico. A avaliação psicológica poderá ser importante na abordagem diagnóstica e terapêutica destes doentes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Background:  Urticaria is characterised by the presence of pruritic erythematous maculopapular lesions, associated or not with angioedema, and chronic urticaria is estimated to affect up to 1% of the population at some time in life. Chronic spontaneous urticaria (CSU), due to its clinical features may significantly affect the performance of daily activities and the quality of sleep. Some studies suggest that emotional disorders may be an important triggering factor in CSU.  Objectives:  This study aimed to explore the association of chronic spontaneous urticaria with psychiatric disorders by assessing the consumption of psychotropic drugs by patients with CSU.  Methods:  This was a retrospective study of adult patients evaluated in a first appointment in the Allergy and Immunology Department over one year, comparing data from a study group with CSU with a control group including patients evaluated over the same period for respiratory disease, matched with the study group in gender and age group. The use of psycho drugs by the patient was obtained from the clinical history and through the application of Electronic Medical Prescription. Statistical analysis was performed in SPSS version 22, and for comparison of the groups, the X2 test with 95% confidence interval was used. Results: Sixty patients were included in the CSU study group and 120 patients in the control group. Overall, there was no statistically significant difference (p=0.054) in the consumption of psychoactive drugs between the groups assessed. However, the study group tended to have a higher consumption of anxiolytics and sedatives. When we evaluate by pharmacological class, patients in the study group showed a greater tendency to consume more than one psychoactive drugs (p= 0.017), regardless of the drug involved.  Conclusions:  Patients with CSU are more likely to use more than one psychotropic drug, regardless of the pharmacological group. Psychological evaluation may be important in these patients&#8217; diagnostic and therapeutic approaches.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Psicofármacos]]></kwd>
<kwd lng="pt"><![CDATA[saúde mental]]></kwd>
<kwd lng="pt"><![CDATA[urticária]]></kwd>
<kwd lng="pt"><![CDATA[urticária crónica espontânea]]></kwd>
<kwd lng="en"><![CDATA[Chronic spontaneous urticaria]]></kwd>
<kwd lng="en"><![CDATA[mental health]]></kwd>
<kwd lng="en"><![CDATA[psycho drugs]]></kwd>
<kwd lng="en"><![CDATA[urticaria]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zuberbier]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Aberer]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Asero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Abdul Latiff]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Baker]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ballmer-Weber]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria]]></article-title>
<source><![CDATA[Allergy]]></source>
<year>2018</year>
<volume>73</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uguz]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Engin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Yilmaz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria]]></article-title>
<source><![CDATA[J Psychosom Res]]></source>
<year>2008</year>
<volume>64</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weldon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life in patients with urticaria and angioedema: Assessing burden of disease]]></article-title>
<source><![CDATA[Allergy Asthma Proc]]></source>
<year>2014</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Xiao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Meta-analysis of observational studies on the association of chronic urticaria with symptoms of depression and anxiety]]></article-title>
<source><![CDATA[Front Med]]></source>
<year>2020</year>
<volume>7</volume>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GPEU - Grupo Português de Estudos de Urticária O behalf of. Abordagem Diagnóstica e Terapêutica da Urticária Crónica Espontânea: Recomendações em Portugal]]></article-title>
<source><![CDATA[Acta Med Port]]></source>
<year>2016</year>
<volume>29</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DeLong]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
<name>
<surname><![CDATA[Culler]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Saini]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Beck]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Annual direct and indirect health care costs of chronic idiopathic urticaria]]></article-title>
<source><![CDATA[Arch Dermatol]]></source>
<year>2008</year>
<volume>144</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maurer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ortonne]]></surname>
<given-names><![CDATA[J-P]]></given-names>
</name>
<name>
<surname><![CDATA[Zuberbier]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic urticaria: A patient survey on quality-of-life, treatment usage and doctor-patient relation]]></article-title>
<source><![CDATA[Allergy]]></source>
<year>2009</year>
<volume>64</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zuberbier]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Maurer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Omalizumab for the treatment of chronic urticaria]]></article-title>
<source><![CDATA[Expert Rev Clin Immunol]]></source>
<year>2015</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>171-80</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Estudo Epidemiológico Nacional de Saúde Mental]]></article-title>
<source><![CDATA[Faculdade de Ciências Médicas UN de L]]></source>
<year>2013</year>
<edition>1</edition>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[IV Inquérito Nacional ao Consumo de Substâncias Psicoativas na População Geral]]></article-title>
<source><![CDATA[Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lyketsos]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Stratigos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tawil]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Psaras]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lyketsos]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hostile personality characteristics, dysthymic states and neurotic symptoms in urticaria, psoriasis and alopecia]]></article-title>
<source><![CDATA[Psychother Psychosom]]></source>
<year>1985</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Polenghi]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Molinari]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gala]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Guzzi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Garutti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Finzi]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experience with psoriasis in a psychosomatic dermatology clinic]]></article-title>
<source><![CDATA[Acta Dermato-Venereologica]]></source>
<year>1994</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic idiopathic urticaria and anxiety symptoms]]></article-title>
<source><![CDATA[J Health Psychol]]></source>
<year>2011</year>
<volume>16</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urticária da clínica à terapêutica]]></article-title>
<source><![CDATA[Merck Sharpe &amp; Dohme]]></source>
<year>2010</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Georgin-Lavialle]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moura]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Salvador]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chauvet-Gelinier]]></surname>
<given-names><![CDATA[J-C]]></given-names>
</name>
<name>
<surname><![CDATA[Launay]]></surname>
<given-names><![CDATA[J-M]]></given-names>
</name>
<name>
<surname><![CDATA[Damaj]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mast cells&#8217; involvement in inflammation pathways linked to depression: evidence in mastocytosis]]></article-title>
<source><![CDATA[Mol Psychiatry]]></source>
<year>2016</year>
<volume>21</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nautiyal]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Pfaff]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Silver]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Brain mast cells link the immune system to anxiety-like behavior]]></article-title>
<source><![CDATA[Proc Natl Acad Sci]]></source>
<year>2008</year>
<volume>105</volume>
<numero>46</numero>
<issue>46</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yuan]]></surname>
<given-names><![CDATA[HP]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[XP]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[FK]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[YQ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anxiety and depression are associated with increased counts and degranulation of duodenal mast cells in functional dyspepsia]]></article-title>
<source><![CDATA[Int J Clin Exp Med]]></source>
<year>2015</year>
<volume>8</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Theoharides]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Alysandratos]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Angelidou]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Delivanis]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Sismanopoulos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mast cells and inflammation]]></article-title>
<source><![CDATA[Biochimica et Biophysica Acta - Molecular Basis of Disease]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[RC-M]]></given-names>
</name>
<name>
<surname><![CDATA[Mak]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[nterleukin (IL)-6, tumour necrosis factor alpha (TNF-&#945;) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A metaanalysis and meta-regression]]></article-title>
<source><![CDATA[J Affect Disord]]></source>
<year>2012</year>
<volume>139</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>230-9</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dantzer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cytokine, sickness behavior, and depression]]></article-title>
<source><![CDATA[Immunology and Allergy Clinics of North America]]></source>
<year>2009</year>
<volume>29</volume>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dowlati]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Herrmann]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Swardfager]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sham]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Reim]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Meta-analysis of cytokines in major depression]]></article-title>
<source><![CDATA[Biol Psychiatry]]></source>
<year>2010</year>
<volume>67</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conti]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Caraffa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ronconi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Conti]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Kritas]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Mastrangelo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers)]]></article-title>
<source><![CDATA[Immunologic Research]]></source>
<year>2018</year>
<volume>66</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
